[A Case of Resected Gastric Cancer Invading the Esophagus with Esophageal Recurrence That Responded to Weekly Docetaxel/Cisplatin Chemotherapy].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 26489580)

Published in Gan To Kagaku Ryoho on October 01, 2015

Authors

Yukio Maezawa1, Tsutomu Hayashi, Jun Yamamoto, Hiroshi Ohnishi, Nobutoshi Horii, Hirohide Inoue, Jun Kimura, Ryo Takagawa, Hirochika Makino, Yoshihiro Suzuki, Takashi Ohshima, Akira Tsuburaya, Yasushi Rino, Chikara Kunisaki, Munetaka Masuda

Author Affiliations

1: Dept. of Surgery, Gastroenterological Center, Yokohama City University Medical Center.

Articles by these authors

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature (2004) 4.92

Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96

Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology (2011) 2.36

Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Trends Cell Biol (2009) 2.19

Systematic expression profiling of the mouse transcriptome using RIKEN cDNA microarrays. Genome Res (2003) 1.98

Negative regulation of phagocytosis in macrophages by the CD47-SHPS-1 system. J Immunol (2005) 1.86

Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65

Predictive factors for surgical complications of laparoscopy-assisted distal gastrectomy for gastric cancer. Surg Endosc (2008) 1.64

Estrogen determines sex differences in airway responsiveness after allergen exposure. Am J Respir Cell Mol Biol (2007) 1.63

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer (2011) 1.58

Risk analysis and improvement of strategies in patients who have acute type A aortic dissection with coronary artery dissection. Eur J Cardiothorac Surg (2013) 1.56

Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study. Gastric Cancer (2012) 1.54

Overexpressed cyclo-oxygenase-2 in the background liver is associated with the clinical course of hepatitis C virus-related cirrhosis patients after curative surgery for hepatocellular carcinoma. J Gastroenterol Hepatol (2007) 1.49

Effects of experimental focal compression on excitability of human median motor axons. Clin Neurophysiol (2008) 1.48

Impact of lymph-node metastasis site in patients with thoracic esophageal cancer. J Surg Oncol (2010) 1.45

Efficacy of repeat hepatic resection for recurrent hepatocellular carcinomas. ANZ J Surg (2009) 1.44

F-wave latencies in patients with diabetes mellitus. Muscle Nerve (2014) 1.42

A Y-shaped vinyl hood that creates pneumoperitoneum in laparoscopic rectal cancer surgery (Y-hood method.): a new technique for laparoscopic low anterior resection. Surg Endosc (2009) 1.40

Mechanical cardiac support system for patients with postcardiotomy cardiogenic shock: analysis of risk factors for survival. Jpn J Thorac Cardiovasc Surg (2004) 1.38

Usefulness of enhanced recovery after surgery protocol as compared with conventional perioperative care in gastric surgery. Gastric Cancer (2011) 1.36

Learning curve for laparoscopy-assisted distal gastrectomy with regional lymph node dissection for early gastric cancer. Surg Laparosc Endosc Percutan Tech (2008) 1.34

A 10-year experience with the Carbomedics cardiac prosthesis. Ann Thorac Surg (2005) 1.33

Protein tyrosine phosphatase SHP-2: a proto-oncogene product that promotes Ras activation. Cancer Sci (2009) 1.32

Clinical significance of BRAF (V600E) mutation and Ki-67 labeling index in papillary thyroid carcinomas. Anticancer Res (2007) 1.29

The role of G-protein-coupled receptor kinase 5 in pathogenesis of sporadic Parkinson's disease. J Neurosci (2006) 1.28

A prospective feasibility and safety study of laparoscopy-assisted distal gastrectomy for clinical stage I gastric cancer initiated by surgeons with much experience of open gastrectomy and laparoscopic surgery. Gastric Cancer (2012) 1.26

Clinical diagnosis of metastatic gastric tumors: clinicopathologic findings and prognosis of nine patients in a single cancer center. World J Surg (2004) 1.26

Application of the transorally inserted anvil (OrVil) after laparoscopy-assisted total gastrectomy. Surg Endosc (2010) 1.26

Asymmetric alkynylation of aldehydes catalyzed by an In(III)/BINOL complex. J Am Chem Soc (2005) 1.25

Axillary lymph node metastasis from papillary thyroid carcinoma: report of a case. Surg Today (2007) 1.25

Role of chemotherapy for advanced/recurrent gastric cancer: an individual-patient-data meta-analysis. Eur J Cancer (2013) 1.24

Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis. Am J Pathol (2009) 1.24

Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer. Ann Surg Oncol (2008) 1.23

Osteoclast-like giant cell tumor of the pancreas. Int J Clin Oncol (2002) 1.23

Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer (2003) 1.23

Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas. Lung Cancer (2009) 1.22

Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center. World J Surg (2009) 1.20

Expression of the potential cancer stem cell markers, CD133, CD44, ALDH1, and β-catenin, in primary lung adenocarcinoma--their prognostic significance. Pathol Int (2012) 1.20

Direct observation of anisotropic interparticle forces in nematic colloids with optical tweezers. Phys Rev Lett (2004) 1.18

Phase II study of preoperative chemotherapy with S-1 and cisplatin followed by gastrectomy for clinically resectable type 4 and large type 3 gastric cancers (JCOG0210). J Surg Oncol (2013) 1.18

High false-negative proportion of intraoperative histological examination as a serious problem for clinical application of sentinel node biopsy for early gastric cancer: final results of the Japan Clinical Oncology Group multicenter trial JCOG0302. Gastric Cancer (2013) 1.16

Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42. Mol Biol Cell (2004) 1.16

Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases. Pathol Int (2012) 1.16

Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: three-gene expression model predicts clinical response. Int J Cancer (2006) 1.16

Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol (2012) 1.15

Prognostic value of CD133 expression in stage I lung adenocarcinomas. Int J Clin Exp Pathol (2010) 1.14

Enantio- and diastereoselective catalytic Mannich-type reaction of a glycine schiff base using a chiral two-center phase-transfer catalyst. Angew Chem Int Ed Engl (2005) 1.13

A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). Gastric Cancer (2010) 1.13

Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol Rep (2011) 1.12

Prognostic factors after resection of pancreatic cancer. World J Surg (2009) 1.11

Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. Gynecol Oncol (2010) 1.11

Solitary metastasis to the left axillary lymph node after curative gastrectomy in gastric cancer. Gastric Cancer (2002) 1.11

Role of the CD47-SHPS-1 system in regulation of cell migration. EMBO J (2003) 1.10

Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension. J Clin Endocrinol Metab (2006) 1.09

Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity. J Immunol (2012) 1.09

Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol Rep (2008) 1.08

SHPS-1 promotes the survival of circulating erythrocytes through inhibition of phagocytosis by splenic macrophages. Blood (2005) 1.08

Phase II trial of S-1 for neoadjuvant chemotherapy against scirrhous gastric cancer (JCOG 0002). Gastric Cancer (2009) 1.06

Total aortic arch replacement through the L-incision approach. Ann Thorac Surg (2003) 1.06

Essential role of Notch signaling in effector memory CD8+ T cell-mediated airway hyperresponsiveness and inflammation. J Exp Med (2008) 1.05

Positive regulation of phagocytosis by SIRPbeta and its signaling mechanism in macrophages. J Biol Chem (2004) 1.05

Early growth response-1 induces and enhances vascular endothelial growth factor-A expression in lung cancer cells. Am J Pathol (2010) 1.04

Does the surgical stress associated with palliative resection for patients with incurable gastric cancer with distant metastasis shorten their survival? Hepatogastroenterology (2004) 1.04

Clinical outcome of different modes of resection in papillary thyroid carcinomas with laryngotracheal invasion. Langenbecks Arch Surg (2006) 1.04

Virus-specific IgE enhances airway responsiveness on reinfection with respiratory syncytial virus in newborn mice. J Allergy Clin Immunol (2008) 1.03

CD47 promotes neuronal development through Src- and FRG/Vav2-mediated activation of Rac and Cdc42. J Neurosci (2006) 1.03

Superior vena cava (SVC) reconstruction using autologous tissue in two cases of differentiated thyroid carcinoma presenting with SVC syndrome. World J Surg Oncol (2009) 1.02

Regulation by SIRPα of dendritic cell homeostasis in lymphoid tissues. Blood (2010) 1.02

Neoadjuvant chemotherapy for gastric cancer in Japan: a standing position by comparing with adjuvant chemotherapy. Surg Today (2013) 1.02

Morphometric profiling of lung cancers-its association with clinicopathologic, biologic, and molecular genetic features. Am J Surg Pathol (2010) 1.01

Impact of lymphovascular invasion in patients with stage I gastric cancer. Surgery (2009) 1.00

Reduction of bone cancer pain by CB1 activation and TRPV1 inhibition. J Anesth (2010) 1.00